RBI has relaxed timeline for compliance with various payment system requirements
All existing non-bank PPI issuers (at the time of issuance of PPI-MD) to comply with the minimum positive net worth requirement of Rs.15 crore for the financial position as September 30, 2021.
RBI opens Sovereign Gold Bond Scheme 2021-22 Series I
RBI opens Sovereign Gold Bond Scheme 2021-22 Series I from 17.05.2021 to 21.05.2021.
The nominal value of the bond is ₹4,777 per gram of gold and ₹4,727 for investors applying
and paying online.
FSSAI directions for facilitating food businesses during the prevailing COVID-19
FSSAI directions allow FBOs, other than manufacturers, to temporarily operate their businesses on the basis of a valid receipt
of FSSAI license/ registration application having 17- digit Application Reference Number (ARN) generated
upon online application and fee payment on FoSCoS.
SEBI enhances the foreign investment limit of AIF/VCF.
At present, Sebi-registered alternative investment funds (AIF) or venture capital funds (VCF) are permitted to invest overseas, subject to an overall limit of USD 750 million. However it has now been enhanced to USD 1,500 million.
Government of Andhra Pradesh declares mucormycosis as notifiable disease under epidemic diseases Act.
All Health Care facilities shall report each and every suspected or confirmed cases to the health department and shall follow the guidelines for screening, diagnosis and management of mucormycetes issued by the health ministry.
Union Ministry of Ayush launches AYUSH COVID -19 Counselling Helpline.
Through the helpline 14443, experts from different streams of Ayush, namely Ayurveda, Homeopathy, Yoga, Naturopathy, Unani & Siddha would be available to address queries of the general masses.
DST invites applications from startups and companies for developing new technologies and innovative products to tackle the second COVID wave.
NIDHI4COVID2.0, a new initiative under which the companies can apply, will fund eligible start-ups & companies registered in India offering promising solutions in the thrust areas of oxygen innovation, portable solution, relevant medical accessories, diagnostic, informatics, or any other solution that addresses/mitigate various challenges faced by country/society due to the severe impact of COVID-19.
